DE BELLIS, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 163
EU - Europa 109
AS - Asia 26
OC - Oceania 1
Totale 299
Nazione #
US - Stati Uniti d'America 160
IT - Italia 86
VN - Vietnam 18
IE - Irlanda 10
IN - India 6
DE - Germania 4
CA - Canada 3
SE - Svezia 3
CN - Cina 2
FI - Finlandia 2
FR - Francia 2
CZ - Repubblica Ceca 1
GB - Regno Unito 1
NZ - Nuova Zelanda 1
Totale 299
Città #
Chandler 45
Naples 32
Princeton 31
Ashburn 24
Dong Ket 18
Dublin 10
Nocera Inferiore 9
Salerno 8
Pune 6
Ann Arbor 4
Andover 3
Marano Di Napoli 3
Redwood City 3
Toronto 3
Wilmington 3
Boardman 2
Fairfield 2
Fremont 2
Lappeenranta 2
Milan 2
Monteforte Irpino 2
Novara 2
Seattle 2
Borgo San Michele 1
Brno 1
Bury 1
Cava De' Tirreni 1
Dunedin 1
Fisciano 1
Hanover 1
Houston 1
Jinan 1
Jonesboro 1
Marigliano 1
Munich 1
Norwalk 1
Pittsburgh 1
Reggio Calabria 1
Washington 1
Totale 234
Nome #
Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics. 67
Sirt1 activity in pbmcs as a biomarker of different heart failure phenotypes 44
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 39
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19 34
The role of pharmacogenetics for antithrombotic therapy management: new achievements and barriers yet to overcome 33
PD-L1 Dysregulation in COVID-19 Patients 25
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 24
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 23
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 12
Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature 9
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 3
Low-Dose NSAIDs Efficacy in Orthopedic Applications. 1
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 1
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 1
Totale 316
Categoria #
all - tutte 1.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 2 13 13 3 4 2 0 18
2021/202267 6 0 2 2 9 1 0 1 5 0 16 25
2022/2023129 8 16 33 13 3 21 4 6 11 1 12 1
2023/202465 5 8 4 7 7 20 0 9 2 3 0 0
Totale 316